EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022
March 21, 2022 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, March 31, at 8:30 am ET LYON, France, March 21, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...
EDAP Issues Letter to Shareholders
February 01, 2022 08:00 ET
|
EDAP TMS S.A.
LYON, France, February 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders: To my...
EDAP Announces Publication of Positive Pre-clinical Results Using Intraoperative HIFU Ablation of the Pancreas in the Journal Cancers
January 13, 2022 08:00 ET
|
EDAP TMS S.A.
Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global...
EDAP Provides Corporate Update on US Focal One Installation Growth
January 05, 2022 08:00 ET
|
EDAP TMS S.A.
Company announces several key U.S. Focal One installations during Q4 LYON, France, January 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based...
EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 29, 2021 09:30 ET
|
EDAP TMS S.A.
LYON, France, November 29, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will participate in a fireside chat...
Sarcos Technology and Robotics Corporation to Participate in Upcoming Investor Conference
November 22, 2021 09:00 ET
|
Sarcos Corp.
SALT LAKE CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC and STRCW) will participate in the following investor conference on Wednesday,...
EDAP Reports Third Quarter 2021 Results and Provides Operational Update
November 17, 2021 16:35 ET
|
EDAP TMS S.A.
Year-to-date revenue of approximately EUR 30.1 million (USD 35.9 million) increased 14.4% year-over-year Q3 revenue of EUR 9.4 million (USD 11.1 million), flat with Q3 2020, reflecting lingering...
EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021
November 10, 2021 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET LYON, France, November 10, 2021 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound,...
EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program
September 28, 2021 08:00 ET
|
EDAP TMS S.A.
Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest LYON, France, September 28, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional
September 16, 2021 08:00 ET
|
FluroTech Ltd.
CALGARY, Alberta, Sept. 16, 2021 (GLOBE NEWSWIRE) -- FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...